SCHEMBL2432095

SCHEMBL2432095

O=c1c2ncccc2nc(CCNc2ncnc3[nH]cnc23)n1-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 8/20 0.41
ALDH1A1 P00352 1/20 0.40
HSD17B10 Q99714 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
PDE4D Q08499 2/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
MAPT P10636 2/20 0.38
EGFR P00533 1/20 0.37
PIK3CG P48736 5/20 0.36
PIK3CA P42336 4/20 0.36
PIK3CB P42338 4/20 0.36
PIK3R1 P27986 4/20 0.36
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
PDE10A Q9Y233 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5607475 0.89 ALDH1A1 (0.50) PIK3CDALDH1A1HSD17B10RXFP1MAPT
SCHEMBL12472046 0.87 MAPT (0.44) PDE4DPDE4APDE4BPDE4CMAPT
SCHEMBL5606978 0.84 PIK3CG (0.51) PIK3CDPDE4DPIK3CGPIK3CAPIK3CB
SCHEMBL5606808 0.84 PIK3CD (0.51) PIK3CDPDE4DPIK3CGPIK3CAPIK3CB
SCHEMBL14993340 0.84 PIK3CD (0.51) PIK3CDPIK3CGPIK3CAPIK3CBPIK3R1
SCHEMBL5608379 0.84 ALDH1A1 (0.48) PIK3CDALDH1A1HSD17B10RXFP1MAPT
SCHEMBL4234577 0.83 PIK3CD (0.50) PIK3CDALDH1A1HSD17B10RXFP1PDE4D
SCHEMBL5607282 0.83 PIK3CD (0.41) PIK3CDALDH1A1HSD17B10RXFP1PDE4D
SCHEMBL2323929 0.83 PIK3CD (0.51) PIK3CDALDH1A1HSD17B10RXFP1PIK3CG
SCHEMBL5607766 0.82 PIK3CD (0.51) PIK3CDALDH1A1HSD17B10RXFP1PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2365810-A2 PHOSPHATIDYLINOSITOL-3-KINASE P110 DELTA-TARGETED DRUGS IN THE TREATMENT OF CNS DISORDERS The U.S.A. As Represented By The Secretary, Department Of Health And Human Services (US) 2011-09-21 EP disclosed
EP-2220089-A2 INHIBITORS OF HUMAN PHOSPHATIDYL-INOSITOL 3-KINASE DELTA ICOS CORPORATION (US) 2010-08-25 EP disclosed
WO-2010065923-A2 PHOSPHATIDYLINOSITOL-3-KINASE P110 DELTA-TARGETED DRUGS IN THE TREATMENT OF CNS DISORDERS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2010-06-10 WO disclosed
WO-2009064802-A2 INHIBITORS OF HUMAN PHOSPHATIDYL-INOSITOL 3-KINASE DELTA ELI LILLY & CO. (US) 2009-05-22 WO disclosed